JERIN BRYANT: Open Payments
NPI 1881881274 · KINGSVILLE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$889 in 48 payments from 12 companies in 2025. Trend: 2023 $1,401 · 2024 $1,370 · 2025 $889
Food & beverage: $889
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 14 | $289 |
| Lilly USA, LLC | 14 | $198 |
| AstraZeneca Pharmaceuticals LP | 6 | $149 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $70 |
| Exact Sciences Corporation | 2 | $42 |
| Kowa Pharmaceuticals America, Inc. | 2 | $40 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $18 |
| Amgen Inc. | 1 | $18 |
| Sumitomo Pharma America, Inc. | 1 | $17 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $17 |
Products named: Ozempic, MOUNJARO, FARXIGA, JARDIANCE, Rybelsus, Cologuard Collection Kit, ZORYVE, BREZTRI.
Industry payments across TX — which companies pay providers there.
